Glucocorticoid-induced osteoporosis: an update
J Compston - Endocrine, 2018 - Springer
Glucocorticoid-induced osteoporosis is the most common secondary cause of osteoporosis
and the resulting fractures cause significant morbidity. Following initiation of oral …
and the resulting fractures cause significant morbidity. Following initiation of oral …
Management of endocrine disease: secondary osteoporosis: pathophysiology and management
F Mirza, E Canalis - European journal of endocrinology, 2015 - academic.oup.com
Osteoporosis is a skeletal disorder characterized by decreased mass and compromised
bone strength predisposing to an increased risk of fractures. Although idiopathic …
bone strength predisposing to an increased risk of fractures. Although idiopathic …
Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians
A Qaseem, MA Forciea, RM McLean… - Annals of internal …, 2017 - acpjournals.org
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A
Clinical Practice Guideline Update From the American College of Physicians | Annals of Internal …
Clinical Practice Guideline Update From the American College of Physicians | Annals of Internal …
Vitamin D supplementation for prevention of mortality in adults
Background Available evidence on the effects of vitamin D on mortality has been
inconclusive. In a recent systematic review, we found evidence that vitamin D 3 may …
inconclusive. In a recent systematic review, we found evidence that vitamin D 3 may …
Glucocorticoid-induced osteoporosis
K Briot, C Roux - RMD open, 2015 - rmdopen.bmj.com
Corticosteroid-induced osteoporosis is the most common form of secondary osteoporosis
and the first cause in young people. Bone loss and increased rate of fractures occur early …
and the first cause in young people. Bone loss and increased rate of fractures occur early …
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
Although glucocorticoids may effectively be used in the management of many inflammatory
conditions, their use is associated with significant morbidity and mortality. Osteoporosis, with …
conditions, their use is associated with significant morbidity and mortality. Osteoporosis, with …
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical …
Objective: Systemic lupus erythematosus (SLE) is a complex disease with variable
presentations, course and prognosis. We sought to develop evidence-based …
presentations, course and prognosis. We sought to develop evidence-based …
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
KG Saag, R Emkey, TJ Schnitzer… - … England Journal of …, 1998 - Mass Medical Soc
Background Osteoporosis is a common complication of long-term glucocorticoid therapy for
which there is no well-proved preventive or restorative treatment. Methods We carried out …
which there is no well-proved preventive or restorative treatment. Methods We carried out …
Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease
EM Scott, I Gaywood, BB Scott - Gut, 2000 - gut.bmj.com
Osteoporotic fractures are a major public health problem. It has been estimated that in the
USA the remaining lifetime fracture risk at the age of 50 years is 40% for white women and …
USA the remaining lifetime fracture risk at the age of 50 years is 40% for white women and …
Vitamin D and bone health; Potential mechanisms
Osteoporosis is associated with increased morbidity, mortality and significant economic and
health costs. Vitamin D is a secosteriod hormone essential for calcium absorption and bone …
health costs. Vitamin D is a secosteriod hormone essential for calcium absorption and bone …